Clinical Trials Directory

Trials / Completed

CompletedNCT07113145

Comparative Evaluation of Safety and Efficacy of Dapoxetine, Silodosin, and Citalopram in the Management of Premature Ejaculation

Comparative Evaluation of Safety and Efficacy of Dapoxetine, Silodosin, and Citalopram in the Management of Premature Ejaculation: A Randomized Clinical Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
450 (actual)
Sponsor
Beni-Suef University · Academic / Other
Sex
Male
Age
20 Years
Healthy volunteers
Not accepted

Summary

This randomized controlled trial evaluated the comparative effectiveness and safety of four pharmacological treatments-Citalopram 20mg, Silodosin 4 mg, Dapoxetine 30 mg on demand, and Dapoxetine 30 mg daily-in men with premature ejaculation (PE). A total of 400 male patients were enrolled at Beni-Suef University Hospital and randomly assigned to one of four treatment groups (n=100). The primary outcome was the change in intravaginal ejaculatory latency time (IVELT), while secondary outcomes included ejaculatory control and sexual satisfaction, assessed using the Premature Ejaculation Profile Questionnaire (PEPQ). Side effects were also evaluated using multivariate regression analysis.

Conditions

Interventions

TypeNameDescription
DRUGOral intake of medication● Group A: Received Citalopram hydrobromide, starting with 10 mg once daily for 1 week, followed by 20 mg once daily for 10 weeks, and 10 mg daily during the final week (tapered).
DRUGOral intake of medication● Group B: Received Silodosin 4mg, administered orally once daily.
DRUGOral intake of medication● Group C: Received Dapoxetine hydrochloride 30 mg, taken 2 hours before intercourse, on-demand, minimum of 8 times/month for 3 months.
DRUGOral intake of medication● Group D: Received Dapoxetine hydrochloride 30 mg, administered daily.

Timeline

Start date
2024-06-01
Primary completion
2025-01-01
Completion
2025-03-01
First posted
2025-08-08
Last updated
2025-08-08

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07113145. Inclusion in this directory is not an endorsement.

Comparative Evaluation of Safety and Efficacy of Dapoxetine, Silodosin, and Citalopram in the Management of Premature Ej (NCT07113145) · Clinical Trials Directory